JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
Christian O. Henry, a director at Wave Life Sciences LTD (NASDAQ:WVE), sold 9,670 ordinary shares of the company on August 13, 2025, for approximately $85,192. The stock, currently trading at $8.76, has shown remarkable strength with a 57% return over the past year. According to InvestingPro data, analyst price targets for Wave Life Sciences range from $9 to $36, suggesting potential upside.
The sales were executed at prices ranging from $8.45 to $9.03 per share. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 24, 2024.
On August 11, 2025, Henry also acquired 12,700 shares of Wave Life Sciences as a restricted share unit award with a value of $0. Additionally, he was granted options to purchase 76,200 ordinary shares at an exercise price of $8.105.
Following the sale, Henry directly owns 29,645 shares of Wave Life Sciences.
In other recent news, Wave Life Sciences has garnered attention from multiple research firms, each initiating or reiterating positive ratings on the company. Canaccord Genuity initiated coverage with a Buy rating, citing the company’s strong pipeline of RNA-based medicines, including WVE-006, which is expected to release multidose data in the third quarter of 2024. Oppenheimer also initiated coverage with an Outperform rating, highlighting the company’s innovative PRISM platform that supports four clinical-stage programs. Citi joined the positive sentiment with a Buy rating, noting several near-term catalysts that could drive potential upside, although they classified the stock as "Buy/High Risk."
Additionally, Cantor Fitzgerald reiterated its Overweight rating, maintaining a price target of $10.00 after hosting a virtual webinar with Wave’s CEO. The firm emphasized the therapeutic approach targeting activin signaling pathways, which may offer advantages when combined with incretin therapies. These developments reflect growing confidence in Wave Life Sciences’ strategic direction and potential for future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.